Merit Medical Systems Plans Third Quarter 2024 Results Update
Merit Medical Systems to Share Financial Results
Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent name in healthcare technology, is set to announce its financial results for the third quarter of 2024. The official release will occur after the market closes on a designated day in late October. This event marks an essential moment for investors and stakeholders who are eager for insights into the company's performance during the past quarter.
Investor Conference Call Details
On the same day as the financial announcement, Merit Medical will host an investor conference call at 5:00 p.m. Eastern time. This call aims to provide detailed discussions surrounding the earnings report, adjusting any uncertainties, and addressing questions from the investor community. It's a great opportunity for interested parties to engage directly with company representatives.
How to Participate in the Conference Call
To participate in the investor conference call, potential attendees are encouraged to pre-register to receive confirmation and detailed dial-in information. There will also be live webcasting available, ensuring broader access for those who may not be able to join the call directly. Furthermore, all the required links for registration and access will be available through Merit Medical's official website.
About Merit Medical Systems, Inc.
Merit Medical, founded in 1987, specializes in developing, manufacturing, and distributing key medical devices used in various interventional, diagnostic, and therapeutic practices. Their expertise spans critical areas such as cardiology, radiology, oncology, critical care, and endoscopy. The company is committed to innovation and excellence, boasting a dedicated workforce of over 7,200 employees strategically positioned to serve customers around the globe.
Company Contacts for Investors and Media
The company encourages open communication through established channels for investor and media inquiries. Sarah Comstock represents the PR/Media department, while Mike Piccinino, CFA, IRC handles investor relations. Their contact information is crucial for those wishing to gain more insights or requiring further clarification regarding the company's performance or upcoming announcements.
Frequently Asked Questions
When will Merit Medical announce its Q3 2024 results?
The announcement will take place after the market closes on a specific day in late October 2024.
What time is the investor conference call scheduled?
The investor conference call is slated for 5:00 p.m. Eastern time on the same day as the financial announcement.
How can I access the conference call?
To access the conference call, you must pre-register using the provided links, upon which you'll receive the necessary dial-in details.
What areas does Merit Medical focus on?
Merit Medical specializes in the development of medical devices for interventional, diagnostic, and therapeutic procedures across various fields including cardiology, radiology, and oncology.
Who should I contact for media inquiries?
For media inquiries, you can reach out to Sarah Comstock at Merit Medical.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.